Products for Research Use Only

CEA Antigen (Recombinant)

CAT: 0952-B2014313Size: 0.1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2014313Size:0.1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CEA Antigen (Recombinant)_x000D_ Catalog number: B2014313_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.1 mg_x000D_ Molecular Weight or Concentration: 180 kDa_x000D_ Supplied as: N/A_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: CEA Antigen (recombinant)_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Cannavo E, Sanchez A, Anand R, Ranjha L, Hugener J, Adam C, Acharya A, Weyland N, Aran-Guiu X, Charbonnier JB, Hoffmann ER, Borde V, Matos J, Cejka P. Regulation of the MLH1-MLH3 endonuclease in meiosis Nature. 2020 Oct;586(7830):618-622._x000D_ 2: Kaufman H, Schlom J, Kantor J. A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA) Int J Cancer. 1991 Jul 30;48(6):900-7._x000D_ 3: Marshall J. Carcinoembryonic antigen-based vaccines Semin Oncol. 2003 Jun;30(3 Suppl 8):30-6._x000D_ 4: Cho HI, Kim HJ, Oh ST, Kim TG. In vitro induction of carcinoembryonic antigen (CEA)_specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses Vaccine. 2003 Dec 12;22(2):224-36._x000D_ 5: Bei R, Kantor J, Kashmiri SV, Abrams S, Schlom J. Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen (CEA_) in mice primed with the recombinant vaccinia_CEA J Immunother Emphasis Tumor Immunol. 1994 Nov;16(4):275-82._x000D_ 6: Kass E, Schlom J, Thompson J, Guadagni F, Graziano P, Greiner JW. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA_transgenic mice, by immunizing with a recombinant vaccinia_CEA virus Cancer Res. 1999 Feb 1;59(3):676-83._x000D_ 7: Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia_CEA vaccine J Natl Cancer Inst. 1995 Jul 5;87(13):982-90._x000D_ 8: Wang XB, Zhao BF, Zhao Q, Piao JH, Liu J, Lin Q, Huang HL. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently J Biochem. 2004 Apr;135(4):555-65._x000D_ 9: Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostbck S, Sabzevari H, Schlom J, Hodge JW. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells Vaccine. 2008 Jan 24;26(4):509-21._x000D_ 10: Li D, Hua S, Fan Y, Xu S, Duan X, Liu L, Che Y, Li S, Tan Y. DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice Immunol Lett. 2011 Mar 30;135(1-2):124-8. _x000D_ _x000D_ Products Related to CEA Antigen (Recombinant) can be found at Proteins
CAS Number
9000-83-3
Short Description
Catalog Number: B2014313 (0.1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5